30 years to develop the vaccine against malaria.

WHO has recommended that the first malaria vaccine be widely distributed, a step that could potentially save the lives of tens of thousands of African children each year.

The RTS, S vaccine also known as Mosquirix was developed by the British pharmaceutical company GSK is dry and has already been administered to more than 800,000 children in Ghana, Kenya and Malawi.

Since the pilot program began in 2019, the vaccine that went through lengthy clinical trials has limited efficacy, preventing 39% of malaria cases and 29% of severe cases among the youngest children in Africa during 4 years of trials. however, a latest study found that when children were given both RTS, S, and some antimalarial drugs, there was a 70% reduction in hospitalizations or death.

Experts hope that the WHO announcement will reinvigorate the race to find other vaccines, a search that has been going on for nearly a century; It is noteworthy that the researchers took 30 years to develop this vaccine, unlike the "vaccine" for covid 19 that has skipped innumerable research protocols and were "tested" in the general population, what interests this practice promotes Let me know in the comments what opinion you have.

Thank you for visiting my blog. If you like posts about #science, #planet, #politics, #rights #crypto, #traveling and discovering secrets and beauties of the #universe, feel free to Follow me as these are the topics I write about the most. Have a wonderful day and stay on this great platform :) :)

! The truth will set us free and science is the one that is closest to the truth!